Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder

There is mounting evidence indicating that reactive free radical species are involved in initiation and development of many different forms of human pathologies including psychiatric disorders. In the present study, we aimed to determine whether serum selenium (Se), antioxidant enzyme (glutathione p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2009-02, Vol.33 (1), p.62-65
Hauptverfasser: Ozdemir, Ercan, Cetinkaya, Sevil, Ersan, Serpil, Kucukosman, Seda, Ersan, E. Erdal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 1
container_start_page 62
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 33
creator Ozdemir, Ercan
Cetinkaya, Sevil
Ersan, Serpil
Kucukosman, Seda
Ersan, E. Erdal
description There is mounting evidence indicating that reactive free radical species are involved in initiation and development of many different forms of human pathologies including psychiatric disorders. In the present study, we aimed to determine whether serum selenium (Se), antioxidant enzyme (glutathione peroxidase, GSH-Px, superoxide dismutase, SOD, and catalase, CAT) activities, and plasma malondialdehyde (MDA) levels, a product of lipid peroxidation, were associated with obsessive–compulsive disorder (OCD). The participants were 28 patients with OCD that were drug-free at least for a month and a control group ( n = 28) of healthy subjects, matched with respect to age and sex. In both groups, the levels of the erythrocyte MDA, GSH-Px, SOD, Se, and the CAT were measured. The levels of MDA and SOD were statistically significantly higher ( p < 0.01, p < 0.05 respectively) in patients than controls. The activities of CAT, GSH-Px, and serum Se levels were statistically significantly lower ( p < 0.0001, p < 0.001, and p < 0.001 respectively) in patients than controls. There was a positive correlation in patients between plasma GSH-Px activity and Se concentration ( r = 52, p = 0.001). However, in patients with OCD, CAT and SOD activities were significantly and negatively correlated with MDA levels ( r = − 0.45, p = 0.017 for CAT and r = − 0.54, p = 0.020 for SOD). The study shows the presence of a significant relationship of OCD and oxidative stress, and consequently, an involvement of free radicals and of the antioxidant defence.
doi_str_mv 10.1016/j.pnpbp.2008.10.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66823495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584608003126</els_id><sourcerecordid>20398126</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-c4145645b15cdde0e1b7b34ed9a279351b3241392dae38528e46d696b5d3e7793</originalsourceid><addsrcrecordid>eNqFkc2KFDEQx4Mo7rj6BILkorcZ89Xp9MGDLH7Bggf1HNJJDZshnW5TPaPjSfARfEOfxPTOoDe9pCrFr_6E_Ah5zNmGM66f7zZTnvppIxgzdbJhTN0hK25as1aC67tkxUTtG6P0BXmAuGOMccnkfXLBTde0kssV-fEByn6gCAlyrI3LgU7J4eDo4NKYQ3QpwM0xAE1wgIS3hMtzHL_GUCuF_O04AHV-joc4R0AaM51c7fKM9Eucb-jYIyDGA_z6_tOPw7RPy4WGiGMJUB6Se1uXEB6d6yX59PrVx6u36-v3b95dvbxee8XNvJyq0arpeeNDAAa8b3upIHROtJ1seC-F4rITwYE0jTCgdNCd7psgoa3EJXl2yp3K-HkPONshooeUXIZxj1ZrI6Tqmv-CgsnOcKErKE-gLyNiga2dShxcOVrO7CLJ7uytJLtIWoZVUt16co7f9wOEvztnKxV4egYcepe2xWUf8Q8nOBdtK5agFyeueoFDhGLR12_3EGIBP9swxn8-5DceEbT1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20398126</pqid></control><display><type>article</type><title>Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ozdemir, Ercan ; Cetinkaya, Sevil ; Ersan, Serpil ; Kucukosman, Seda ; Ersan, E. Erdal</creator><creatorcontrib>Ozdemir, Ercan ; Cetinkaya, Sevil ; Ersan, Serpil ; Kucukosman, Seda ; Ersan, E. Erdal</creatorcontrib><description>There is mounting evidence indicating that reactive free radical species are involved in initiation and development of many different forms of human pathologies including psychiatric disorders. In the present study, we aimed to determine whether serum selenium (Se), antioxidant enzyme (glutathione peroxidase, GSH-Px, superoxide dismutase, SOD, and catalase, CAT) activities, and plasma malondialdehyde (MDA) levels, a product of lipid peroxidation, were associated with obsessive–compulsive disorder (OCD). The participants were 28 patients with OCD that were drug-free at least for a month and a control group ( n = 28) of healthy subjects, matched with respect to age and sex. In both groups, the levels of the erythrocyte MDA, GSH-Px, SOD, Se, and the CAT were measured. The levels of MDA and SOD were statistically significantly higher ( p &lt; 0.01, p &lt; 0.05 respectively) in patients than controls. The activities of CAT, GSH-Px, and serum Se levels were statistically significantly lower ( p &lt; 0.0001, p &lt; 0.001, and p &lt; 0.001 respectively) in patients than controls. There was a positive correlation in patients between plasma GSH-Px activity and Se concentration ( r = 52, p = 0.001). However, in patients with OCD, CAT and SOD activities were significantly and negatively correlated with MDA levels ( r = − 0.45, p = 0.017 for CAT and r = − 0.54, p = 0.020 for SOD). The study shows the presence of a significant relationship of OCD and oxidative stress, and consequently, an involvement of free radicals and of the antioxidant defence.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2008.10.004</identifier><identifier>PMID: 18957313</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Adult and adolescent clinical studies ; Antioxidants ; Antioxidants - metabolism ; Anxiety disorders. Neuroses ; Biological and medical sciences ; Female ; Free radicals ; Free Radicals - metabolism ; Humans ; Male ; Malondialdehyde ; Malondialdehyde - blood ; Medical sciences ; Neuropharmacology ; Obsessive-Compulsive Disorder - blood ; Obsessive-Compulsive Disorder - enzymology ; Obsessive-compulsive disorders ; Obsessive–compulsive disorder ; Oxidative Stress ; Pharmacology. Drug treatments ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Selenium ; Selenium - blood</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2009-02, Vol.33 (1), p.62-65</ispartof><rights>2008 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-c4145645b15cdde0e1b7b34ed9a279351b3241392dae38528e46d696b5d3e7793</citedby><cites>FETCH-LOGICAL-c418t-c4145645b15cdde0e1b7b34ed9a279351b3241392dae38528e46d696b5d3e7793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0278584608003126$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21127724$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18957313$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozdemir, Ercan</creatorcontrib><creatorcontrib>Cetinkaya, Sevil</creatorcontrib><creatorcontrib>Ersan, Serpil</creatorcontrib><creatorcontrib>Kucukosman, Seda</creatorcontrib><creatorcontrib>Ersan, E. Erdal</creatorcontrib><title>Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>There is mounting evidence indicating that reactive free radical species are involved in initiation and development of many different forms of human pathologies including psychiatric disorders. In the present study, we aimed to determine whether serum selenium (Se), antioxidant enzyme (glutathione peroxidase, GSH-Px, superoxide dismutase, SOD, and catalase, CAT) activities, and plasma malondialdehyde (MDA) levels, a product of lipid peroxidation, were associated with obsessive–compulsive disorder (OCD). The participants were 28 patients with OCD that were drug-free at least for a month and a control group ( n = 28) of healthy subjects, matched with respect to age and sex. In both groups, the levels of the erythrocyte MDA, GSH-Px, SOD, Se, and the CAT were measured. The levels of MDA and SOD were statistically significantly higher ( p &lt; 0.01, p &lt; 0.05 respectively) in patients than controls. The activities of CAT, GSH-Px, and serum Se levels were statistically significantly lower ( p &lt; 0.0001, p &lt; 0.001, and p &lt; 0.001 respectively) in patients than controls. There was a positive correlation in patients between plasma GSH-Px activity and Se concentration ( r = 52, p = 0.001). However, in patients with OCD, CAT and SOD activities were significantly and negatively correlated with MDA levels ( r = − 0.45, p = 0.017 for CAT and r = − 0.54, p = 0.020 for SOD). The study shows the presence of a significant relationship of OCD and oxidative stress, and consequently, an involvement of free radicals and of the antioxidant defence.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Antioxidants</subject><subject>Antioxidants - metabolism</subject><subject>Anxiety disorders. Neuroses</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Free radicals</subject><subject>Free Radicals - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>Malondialdehyde</subject><subject>Malondialdehyde - blood</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Obsessive-Compulsive Disorder - blood</subject><subject>Obsessive-Compulsive Disorder - enzymology</subject><subject>Obsessive-compulsive disorders</subject><subject>Obsessive–compulsive disorder</subject><subject>Oxidative Stress</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Selenium</subject><subject>Selenium - blood</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2KFDEQx4Mo7rj6BILkorcZ89Xp9MGDLH7Bggf1HNJJDZshnW5TPaPjSfARfEOfxPTOoDe9pCrFr_6E_Ah5zNmGM66f7zZTnvppIxgzdbJhTN0hK25as1aC67tkxUTtG6P0BXmAuGOMccnkfXLBTde0kssV-fEByn6gCAlyrI3LgU7J4eDo4NKYQ3QpwM0xAE1wgIS3hMtzHL_GUCuF_O04AHV-joc4R0AaM51c7fKM9Eucb-jYIyDGA_z6_tOPw7RPy4WGiGMJUB6Se1uXEB6d6yX59PrVx6u36-v3b95dvbxee8XNvJyq0arpeeNDAAa8b3upIHROtJ1seC-F4rITwYE0jTCgdNCd7psgoa3EJXl2yp3K-HkPONshooeUXIZxj1ZrI6Tqmv-CgsnOcKErKE-gLyNiga2dShxcOVrO7CLJ7uytJLtIWoZVUt16co7f9wOEvztnKxV4egYcepe2xWUf8Q8nOBdtK5agFyeueoFDhGLR12_3EGIBP9swxn8-5DceEbT1</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Ozdemir, Ercan</creator><creator>Cetinkaya, Sevil</creator><creator>Ersan, Serpil</creator><creator>Kucukosman, Seda</creator><creator>Ersan, E. Erdal</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20090201</creationdate><title>Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder</title><author>Ozdemir, Ercan ; Cetinkaya, Sevil ; Ersan, Serpil ; Kucukosman, Seda ; Ersan, E. Erdal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-c4145645b15cdde0e1b7b34ed9a279351b3241392dae38528e46d696b5d3e7793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Antioxidants</topic><topic>Antioxidants - metabolism</topic><topic>Anxiety disorders. Neuroses</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Free radicals</topic><topic>Free Radicals - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>Malondialdehyde</topic><topic>Malondialdehyde - blood</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Obsessive-Compulsive Disorder - blood</topic><topic>Obsessive-Compulsive Disorder - enzymology</topic><topic>Obsessive-compulsive disorders</topic><topic>Obsessive–compulsive disorder</topic><topic>Oxidative Stress</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Selenium</topic><topic>Selenium - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozdemir, Ercan</creatorcontrib><creatorcontrib>Cetinkaya, Sevil</creatorcontrib><creatorcontrib>Ersan, Serpil</creatorcontrib><creatorcontrib>Kucukosman, Seda</creatorcontrib><creatorcontrib>Ersan, E. Erdal</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozdemir, Ercan</au><au>Cetinkaya, Sevil</au><au>Ersan, Serpil</au><au>Kucukosman, Seda</au><au>Ersan, E. Erdal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>33</volume><issue>1</issue><spage>62</spage><epage>65</epage><pages>62-65</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>There is mounting evidence indicating that reactive free radical species are involved in initiation and development of many different forms of human pathologies including psychiatric disorders. In the present study, we aimed to determine whether serum selenium (Se), antioxidant enzyme (glutathione peroxidase, GSH-Px, superoxide dismutase, SOD, and catalase, CAT) activities, and plasma malondialdehyde (MDA) levels, a product of lipid peroxidation, were associated with obsessive–compulsive disorder (OCD). The participants were 28 patients with OCD that were drug-free at least for a month and a control group ( n = 28) of healthy subjects, matched with respect to age and sex. In both groups, the levels of the erythrocyte MDA, GSH-Px, SOD, Se, and the CAT were measured. The levels of MDA and SOD were statistically significantly higher ( p &lt; 0.01, p &lt; 0.05 respectively) in patients than controls. The activities of CAT, GSH-Px, and serum Se levels were statistically significantly lower ( p &lt; 0.0001, p &lt; 0.001, and p &lt; 0.001 respectively) in patients than controls. There was a positive correlation in patients between plasma GSH-Px activity and Se concentration ( r = 52, p = 0.001). However, in patients with OCD, CAT and SOD activities were significantly and negatively correlated with MDA levels ( r = − 0.45, p = 0.017 for CAT and r = − 0.54, p = 0.020 for SOD). The study shows the presence of a significant relationship of OCD and oxidative stress, and consequently, an involvement of free radicals and of the antioxidant defence.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>18957313</pmid><doi>10.1016/j.pnpbp.2008.10.004</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2009-02, Vol.33 (1), p.62-65
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_66823495
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Adult and adolescent clinical studies
Antioxidants
Antioxidants - metabolism
Anxiety disorders. Neuroses
Biological and medical sciences
Female
Free radicals
Free Radicals - metabolism
Humans
Male
Malondialdehyde
Malondialdehyde - blood
Medical sciences
Neuropharmacology
Obsessive-Compulsive Disorder - blood
Obsessive-Compulsive Disorder - enzymology
Obsessive-compulsive disorders
Obsessive–compulsive disorder
Oxidative Stress
Pharmacology. Drug treatments
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Selenium
Selenium - blood
title Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A03%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20selenium%20and%20plasma%20malondialdehyde%20levels%20and%20antioxidant%20enzyme%20activities%20in%20patients%20with%20obsessive%E2%80%93compulsive%20disorder&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Ozdemir,%20Ercan&rft.date=2009-02-01&rft.volume=33&rft.issue=1&rft.spage=62&rft.epage=65&rft.pages=62-65&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/j.pnpbp.2008.10.004&rft_dat=%3Cproquest_cross%3E20398126%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20398126&rft_id=info:pmid/18957313&rft_els_id=S0278584608003126&rfr_iscdi=true